Immune Endophenotypes in Children With Autism Spectrum Disorder

Biological Psychiatry

Volumn 81, Issue 5, 2017, Pages 434-441

  Careaga, Milo ^a,b   Rogers, Sally ^b,c   Hansen, Robin L ^b,c   Amaral, David G ^b,c   Van de Water, Judy ^b,c   Ashwood, Paul ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Autism spectrum disorder; Behavior; Children; Cluster analysis; Cytokine; Endophenotyping; Immune

Indexed keywords

GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MONOCYTE CHEMOTACTIC PROTEIN 1; PHYTOHEMAGGLUTININ; TUMOR NECROSIS FACTOR; CCL2 PROTEIN, HUMAN; CYTOKINE;

AGGRESSION; ARTICLE; AUTISM; AUTISM DIAGNOSTIC OBSERVATION SCHEDULE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENDOPHENOTYPE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IN VITRO STUDY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SLEEP DISORDER; T LYMPHOCYTE ACTIVATION; CHEMICALLY INDUCED; IMMUNOLOGY; INFLAMMATION; MONONUCLEAR CELL; PRESCHOOL CHILD;

AUTISM SPECTRUM DISORDER; CHEMOKINE CCL2; CHILD, PRESCHOOL; CYTOKINES; ENDOPHENOTYPES; HUMANS; INFLAMMATION; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-13; INTERLEUKIN-1BETA; INTERLEUKIN-6; LEUKOCYTES, MONONUCLEAR; LIPOPOLYSACCHARIDES; MALE; PHYTOHEMAGGLUTININS;

EID: 84950261621     PISSN: 00063223     EISSN: 18732402     Source Type: Journal    
DOI: 10.1016/j.biopsych.2015.08.036     Document Type: Article

References (48)

1. 1 Autism and Developmental Disabilities Monitoring Network Surveillance Year 2008 Principal Investigators; Centers for Disease Control and Prevention (2012): Prevalence of autism spectrum disorders–Autism and Developmental Disabilities Monitoring Network, 14 sites, United States, 2008. MMWR Surveill Summ 61:1–19.
2. 2 Blumberg, S.J., Bramlett, M.D., Kogan, M.D., Schieve, L.A., Jones, J.R., Lu, M.C., Changes in prevalence of parent-reported autism spectrum disorder in school-aged US children: 2007 to 2011–2012. Natl Health Stat Report 65 (2013), 1–11.
3. 3 Ashwood, P., Wills, S., Van de Water, J., The immune response in autism: A new frontier for autism research. J Leukoc Biol 80 (2006), 1–15.
4. 4 Ashwood, P., Krakowiak, P., Hertz-Picciotto, I., Hansen, R., Pessah, I., Van de Water, J., Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome. Brain Behav Immun 25 (2011), 40–45.
5. 5 Onore, C., Careaga, M., Ashwood, P., The role of immune dysfunction in the pathophysiology of autism. Brain Behav Immun 26 (2012), 383–392.
6. 6 Goines, P.E., Ashwood, P., Cytokine dysregulation in autism spectrum disorders (ASD): Possible role of the environment. Neurotoxicol Teratol 36 (2013), 67–81.
7. 7 Pardo, C.A., Vargas, D.L., Zimmerman, A.W., Immunity, neuroglia and neuroinflammation in autism. Int Rev Psychiatry 17 (2005), 485–495.
8. 8 Cabanlit, M., Wills, S., Goines, P., Ashwood, P., Van de Water, J., Brain-specific autoantibodies in the plasma of subjects with autistic spectrum disorder. Ann N Y Acad Sci 1107 (2007), 92–103.
9. 9 Connolly, A.M., Chez, M., Streif, E.M., Keeling, R.M., Golumbek, P.T., Kwon, J.M., et al. Brain-derived neurotrophic factor and autoantibodies to neural antigens in sera of children with autistic spectrum disorders, Landau-Kleffner syndrome, and epilepsy. Biol Psychiatry 59 (2006), 354–363.
10. 10 Singer, H.S., Morris, C.M., Williams, P.N., Yoon, D.Y., Hong, J.J., Zimmerman, A.W., Antibrain antibodies in children with autism and their unaffected siblings. J Neuroimmunol 178 (2006), 149–155.
11. 11 Todd, R.D., Hickok, J.M., Anderson, G.M., Cohen, D.J., Antibrain antibodies in infantile autism. Biol Psychiatry 23 (1988), 644–647.
12. 12 Wills, S., Cabanlit, M., Bennett, J., Ashwood, P., Amaral, D.G., Van de Water, J., Detection of autoantibodies to neural cells of the cerebellum in the plasma of subjects with autism spectrum disorders. Brain Behav Immun 23 (2009), 64–74.
13. 13 Torres, A.R., Sweeten, T.L., Cutler, A., Bedke, B.J., Fillmore, M., Stubbs, E.G., Odell, D., The association and linkage of the HLA-A2 class I allele with autism. Hum Immunol 67 (2006), 346–351.
14. 14 Torres, A.R., Maciulis, A., Odell, D., The association of MHC genes with autism. Front Biosci 6 (2001), D936–D943.
15. 15 Warren, R.P., Odell, J.D., Warren, W.L., Burger, R.A., Maciulis, A., Daniels, W.W., Torres, A.R., Strong association of the third hypervariable region of HLA-DR beta 1 with autism. J Neuroimmunol 67 (1996), 97–102.
16. 16 Suzuki, K., Matsuzaki, H., Iwata, K., Kameno, Y., Shimmura, C., Kawai, S., et al. Plasma cytokine profiles in subjects with high-functioning autism spectrum disorders. PLoS One, 6, 2011, e20470.
17. 17 Emanuele, E., Orsi, P., Boso, M., Broglia, D., Brondino, N., Barale, F., et al. Low-grade endotoxemia in patients with severe autism. Neurosci Lett 471 (2010), 162–165.
18. 18 Vargas, D.L., Nascimbene, C., Krishnan, C., Zimmerman, A.W., Pardo, C.A., Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann Neurol 57 (2005), 67–81.
19. 19 Li, X., Chauhan, A., Sheikh, A.M., Patil, S., Chauhan, V., Li, X.M., et al. Elevated immune response in the brain of autistic patients. J Neuroimmunol 207 (2009), 111–116.
20. 20 Onore, C.E., Nordahl, C.W., Young, G.S., Van de Water, J.A., Rogers, S.J., Ashwood, P., Levels of soluble platelet endothelial cell adhesion molecule-1 and P-selectin are decreased in children with autism spectrum disorder. Biol Psychiatry 72 (2012), 1020–1025.
21. 21 Nordahl, C.W., Lange, N., Li, D.D., Barnett, L.A., Lee, A., Buonocore, M.H., et al. Brain enlargement is associated with regression in preschool-age boys with autism spectrum disorders. Proc Natl Acad Sci U S A 108 (2011), 20195–20200.
22. 22 Lord, C., Pickles, A., McLennan, J., Rutter, M., Bregman, J., Folstein, S., et al. Diagnosing autism: Analyses of data from the Autism Diagnostic Interview. J Autism Dev Disord 27 (1997), 501–517.
23. 23 Joseph, R.M., Tager-Flusberg, H., Lord, C., Cognitive profiles and social-communicative functioning in children with autism spectrum disorder. J Child Psychol Psychiatry 43 (2002), 807–821.
24. 24 American Psychiatric Association. Quick Reference to the Diagnostic Criteria from DSM-IV-TR. 2000, American Psychiatric Publishing, Inc., Washington, DC.
25. 25 Steinhausen, H.C., Erdin, A., Abnormal psychosocial situations and ICD-10 diagnoses in children and adolescents attending a psychiatric service. J Child Psychol Psychiatry 33 (1992), 731–740.
26. 26 Berument, S.K., Rutter, M., Lord, C., Pickles, A., Bailey, A., Autism screening questionnaire: Diagnostic validity. Br J Psychiatry 175 (1999), 444–451.
27. 27 Mullen, E.M., Mullen Scales of Early Learning. 1995, American Guidance Service, Circle Pines, MN.
28. 28 Achenbach, T.M., The Child Behavior Checklist manual. 1991, The University of Vermont, Burlington, VT.
29. 29 Enstrom, A.M., Onore, C.E., Van de Water, J.A., Ashwood, P., Differential monocyte responses to TLR ligands in children with autism spectrum disorders. Brain Behav Immun 24 (2010), 64–71.
30. 30 Dantzer, R., Kelley, K.W., Autistic children: A neuroimmune perspective. Brain Behav Immun 22 (2008), 804–805.
31. 31 Harden, L.M., du Plessis, I., Poole, S., Laburn, H.P., Interleukin (IL)-6 and IL-1 beta act synergistically within the brain to induce sickness behavior and fever in rats. Brain Behav Immun 22 (2008), 838–849.
32. 32 Moore, A.H., Wu, M., Shaftel, S.S., Graham, K.A., O'Banion, M.K., Sustained expression of interleukin-1beta in mouse hippocampus impairs spatial memory. Neuroscience 164 (2009), 1484–1495.
33. 33 Schneider, H., Pitossi, F., Balschun, D., Wagner, A., del Rey, A., Besedovsky, H.O., A neuromodulatory role of interleukin-1beta in the hippocampus. Proc Natl Acad Sci U S A 95 (1998), 7778–7783.
34. 34 Cacci, E., Claasen, J.H., Kokaia, Z., Microglia-derived tumor necrosis factor-alpha exaggerates death of newborn hippocampal progenitor cells in vitro. J Neurosci Res 80 (2005), 789–797.
35. 35 Krueger, J.M., Obal, F. Jr, Opp, M., Toth, L., Johannsen, L., Cady, A.B., Somnogenic cytokines and models concerning their effects on sleep. Yale J Biol Med 63 (1990), 157–172.
36. 36 Ashwood, P., Krakowiak, P., Hertz-Picciotto, I., Hansen, R., Pessah, I.N., Van de Water, J., Associations of impaired behaviors with elevated plasma chemokines in autism spectrum disorders. J Neuroimmunol 232 (2011), 196–199.
37. 37 Gupta, S., Aggarwal, S., Rashanravan, B., Lee, T., Th1- and Th2-like cytokines in CD4+ and CD8+ T cells in autism. J Neuroimmunol 85 (1998), 106–109.
38. 38 Singh, V.K., Plasma increase of interleukin-12 and interferon-gamma. Pathological significance in autism. J Neuroimmunol 66 (1996), 143–145.
39. 39 Croonenberghs, J., Bosmans, E., Deboutte, D., Kenis, G., Maes, M., Activation of the inflammatory response system in autism. Neuropsychobiology 45 (2002), 1–6.
40. 40 Kustova, Y., Sei, Y., Morse, H.C., Basile, A.S., The influence of a targeted deletion of the IFNγ gene on emotional behaviors. Brain Behav Immun 12 (1998), 308–324.
41. 41 Maes, M., Scharpe, S., Meltzer, H.Y., Okayli, G., Bosmans, E., Dhondt, P., et al. Increased neopterin and interferon-gamma secretion and lower availability of L-tryptophan in major depression - further evidence for an immune-response. Psychiatry Res 54 (1994), 143–160.
42. 42 Derecki, N.C., Cardani, A.N., Yang, C.H., Quinnies, K.M., Crihfield, A., Lynch, K.R., Kipnis, J., Regulation of learning and memory by meningeal immunity: A key role for IL-4. J Exp Med 207 (2010), 1067–1080.
43. 43 Peters, E.M., Liezmann, C., Pavlovic, S., Örsal, A., Rose, M., Kruse, J., 157. HPA axis function is altered by cutaneous allergic inflammation in mice in a neuropeptide- and neurotrophin-dependent manner. Brain Behav Immun 32 (2013), e45–e46.
44. 44 Masi, A., Quintana, D.S., Glozier, N., Lloyd, A.R., Hickie, I.B., Guastella, A.J., Cytokine aberrations in autism spectrum disorder: A systematic review and meta-analysis. Mol Psychiatry 20 (2015), 440–446.
45. 45 Gupta, S., Samra, D., Agrawal, S., Adaptive and innate immune responses in autism: Rationale for therapeutic use of intravenous immunoglobulin. J Clin Immunol 30 (2010), 90–96.
46. 46 Plioplys, A.V., Intravenous immunoglobulin treatment of children with autism. J Child Neurol 13 (1998), 79–82.
47. 47 Sandler, R.H., Finegold, S.M., Bolte, E.R., Buchanan, C.P., Maxwell, A.P., Vaisanen, M.L., et al. Short-term benefit from oral vancomycin treatment of regressive-onset autism. J Child Neurol 15 (2000), 429–435.
48. 48 Asadabadi, M., Mohammadi, M.R., Ghanizadeh, A., Modabbernia, A., Ashrafi, M., Hassanzadeh, E., et al. Celecoxib as adjunctive treatment to risperidone in children with autistic disorder: A randomized, double-blind, placebo-controlled trial. Psychopharmacology (Berl) 225 (2013), 51–59.